These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 2254635)

  • 21. Acute drug-induced hepatitis caused by albendazole.
    Choi GY; Yang HW; Cho SH; Kang DW; Go H; Lee WC; Lee YJ; Jung SH; Kim AN; Cha SW
    J Korean Med Sci; 2008 Oct; 23(5):903-5. PubMed ID: 18955802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XI): cardiovascular system disorders.
    Bankowski Z
    Pharmacoepidemiol Drug Saf; 1998 Sep; 7(5):351-7. PubMed ID: 15073983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XIII): clinical pathology and general disorders.
    Council for International Organization of Medical Sciences
    Pharmacoepidemiol Drug Saf; 1999 May; 8(3):217-24. PubMed ID: 15073931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Definitions of terms for reporting adverse drug reactions (IX): nervous system and psychiatric disorders.
    Council for International Organizations of Medical Sciences
    Pharmacoepidemiol Drug Saf; 1998 Jan; 7(1):39-49. PubMed ID: 15073745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data.
    Cheetham TC; Lee J; Hunt CM; Niu F; Reisinger S; Murray R; Powell G; Papay J
    Pharmacoepidemiol Drug Saf; 2014 Jun; 23(6):601-8. PubMed ID: 24920207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basic requirements for the use of terms for reporting adverse drug reactions (VIII): renal and urinary system disorders.
    Council for International Organizations of Medical Sciences
    Pharmacoepidemiol Drug Saf; 1997 May; 6(3):203-11. PubMed ID: 15073789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary Results of a Novel Algorithmic Method Aiming to Support Initial Causality Assessment of Routine Pharmacovigilance Case Reports for Medication-Induced Liver Injury: The PV-RUCAM.
    Scalfaro E; Streefkerk HJ; Merz M; Meier C; Lewis D
    Drug Saf; 2017 Aug; 40(8):715-727. PubMed ID: 28508325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Updating the French method for the causality assessment of adverse drug reactions.
    Arimone Y; Bidault I; Dutertre JP; Gérardin M; Guy C; Haramburu F; Hillaire-Buys D; Meglio C; Penfornis C; Théophile H; Valnet-Rabier MB;
    Therapie; 2013; 68(2):69-76. PubMed ID: 23773347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation and Reproducibility of the Updated French Causality Assessment Method: an Evaluation by Pharmacovigilance Centres & Pharmaceutical Companies.
    Théophile H; Dutertre JP; Gérardin M; Valnet-Rabier MB; Bidault I; Guy C; Haramburu F; Hillaire-Buys D; Méglio C; Arimone Y
    Therapie; 2015; 70(5):465-76. PubMed ID: 26423144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A challenge for diagnosing acute liver injury with concomitant/sequential exposure to multiple drugs: can causality assessment scales be utilized to identify the offending drug?
    Lim R; Choudry H; Conner K; Karnsakul W
    Case Rep Pediatr; 2014; 2014():156389. PubMed ID: 25506455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Work of the Council for International Organizations of Medical Sciences (CIOMS) in Global Pharmacovigilance.
    Younus MM; Zweygarth M; Rägo L; Harrison-Woolrych M
    Drug Saf; 2020 Nov; 43(11):1067-1071. PubMed ID: 33034859
    [No Abstract]   [Full Text] [Related]  

  • 32. [The international system of drug control].
    Barbadoro E
    Boll Chim Farm; 1990 Mar; 129(3):140-3. PubMed ID: 2245002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of laboratory threshold criteria in drug-induced liver injury detection algorithms for use in pharmacovigilance.
    Tan EH; Ling ZJ; Ang PS; Sung C; Dan YY; Tai BC
    Pharmacoepidemiol Drug Saf; 2020 Nov; 29(11):1480-1488. PubMed ID: 32844466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Causality assessment of drug-induced liver injury. Hepatology Working Group.
    Danan G
    J Hepatol; 1988 Aug; 7(1):132-6. PubMed ID: 3053889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver-unspecific Naranjo scale precise enough to ascertain causality?
    Teschke R; Schmidt-Taenzer W; Wolff A
    Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):567-82. PubMed ID: 21702069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United States.
    Hayashi PH
    Int J Mol Sci; 2016 Feb; 17(2):201. PubMed ID: 26861284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug-induced cutaneous photosensitivity. Results of a consensus meeting].
    Roujeau JC; Beani JC; Dubertret L; Guillaume JC; Jeanmougin M; Danan G; Lagier G; Benichou C
    Therapie; 1989; 44(3):223-7. PubMed ID: 2528839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Causality assessment in pharmacovigilance: The French method and its successive updates.
    Miremont-Salamé G; Théophile H; Haramburu F; Bégaud B
    Therapie; 2016 Apr; 71(2):179-86. PubMed ID: 27080836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and causality assessment in herbal hepatotoxicity.
    Teschke R; Schwarzenboeck A; Eickhoff A; Frenzel C; Wolff A; Schulze J
    Expert Opin Drug Saf; 2013 May; 12(3):339-66. PubMed ID: 23458441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CIOMS and ICH initiatives in pharmacovigilance and risk management: overview and implications.
    Tsintis P; La Mache E
    Drug Saf; 2004; 27(8):509-17. PubMed ID: 15154824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.